Hepatitis C virus (HCV) exists as a complex swarm of genetically related viruses known as a quasispecies. Recent work has shown that quasispecies complexity and evolutionary rates are associated with the outcome of acute infection. Knowledge of how the virus population evolves at different stages of chronic infection is less clear. We have studied rates of evolution of the first hypervariable region (HVR1) of the E2 envelope protein in six individuals with disparate liver disease severity. These data show that virus populations present in individuals with mild nonprogressive liver disease evolve in a typical Darwinian fashion, with a consistent accumulation of non-synonymous (amino acid-changing) substitutions. By contrast, the virus population remains relatively static in individuals with severe progressive liver disease. Possible mechanisms for this disparity are discussed.
Introduction
Hepatitis C virus (HCV), a member of the Flaviviridae family, exhibits a high degree of genetic heterogeneity such that an infected host will harbour a plethora of genetically related yet distinct viral variants collectively termed a quasispecies (Martell et al., 1992) . The propensity for genetic change is associated primarily with the error-prone nature of the RNA-dependent RNA polymerase together with the high HCV replicative rate in vivo (Fukumoto et al., 1996 ; Neumann et al., 1998 ; Ramratnam et al., 1999) .
Approximately 80 % of individuals infected with HCV become chronically infected. The outcome of chronic infection is variable, and the host and viral factors that underlie this variability are poorly understood (Alter et al., 1992 ; Makris et al., 1996 ; Frasca et al., 1999) . Chronic infection is established in the face of humoral and cellular immunity accompanied by the outgrowth of escape mutants present in the viral quasispecies (Honda et al., 1994 ; Gretch et al., 1996 ; Chang et al., 1997 ; Hayashi et al., 1997 ; Lawal et al., 1997 ; Frasca et al., Author for correspondence : Jonathan Ball. 1999 ; Majid et al., 1999 ; Ray et al., 1999 ; Wang & Eckels, 1999) . There is increasing evidence that evolutionary rates of the viral quasispecies at primary infection determine the outcome of acute infection. This association is evident in analyses of the complexity of the envelope genes E1 and E2, particularly the first hypervariable region (HVR1) of E2 (Ray et al., 1999 ; Farci et al., 2000) . It has been proposed that HVR1 of E2 is the major determinant for strain-specific neutralizing antibody responses, and during chronic infection the virus population is able to escape these through continual evolution. There are several lines of evidence to support this. (i) Peptides corresponding to this region can be detected by homologous sera Sekiya et al., 1994 ; Majid et al., 1999) .
(ii) HVR1 monoclonal antibodies are able to partially inhibit E2 binding to cells (Rosa et al., 1996) . (iii) Viral clearance during acute infection is associated with the specificity of the anti-HVR1 response (Zibert et al., 1997 ; Mondelli et al., 1999) . (iv) Pre-treatment of HCV with anti-HVR antibodies prior to inoculation abrogates infectivity in chimpanzees (Farci et al., 1996) . (v) There is a preferential bias for amino acid changing (non-synonymous, Ka) compared to silent (synonymous, Ks) mutations observed in longitudinal sequence analyses (Okamoto et al., 1992 ; Ray et al., 1999) . (vi) HVR1 evolutionary rates are significantly lower in hypogammaglobulinaemic patients (Kumar et al., 1994 ; Booth et al., 1998) . It is clear from this that HVR1 evolution and the ability of the host to respond to newly evolving variants will be crucial determinants of chronic infection outcome. Previous studies aimed at delineating the relationship between viral quasispecies and disease pathogenesis have generated conflicting findings (Naito et al., 1995 ; Gonzalez-Peralta et al., 1996 ; Hayashi et al., 1997 ; Yuki et al., 1997 ; Lopez-Labrador et al., 1999) . Unfortunately, most existing data are derived from cross-sectional comparisons of HVR1 populations and longitudinal study is complicated by antiviral therapy received by most individuals with severe liver disease. Very little is known about the long-term rate of population turnover and evolution and its relationship to liver disease progression and severity. Loss of immune control might lead to virus-induced liver disease and absence of selection would be manifest as a genetically stable viral population. Alternatively, the HVR1 region might continue to be a target for immune selection, irrespective of disease stage, and this would be reflected in the evolutionary changes of the viral quasispecies. Here we describe a thorough investigation of the evolutionary trends of HVR1 in six untreated individuals with severe or mild liver disease in order to address these issues.
Methods
Source of samples. Patients were recruited from the larger Trent HCV Cohort Study of the natural history of HCV infection (Mohsen & The Trent Hepatitis C Virus Study Group, 2001 ). Liver biopsies were taken approximately every 2 years as part of routine diagnostic patient management. Up to nine serial serum samples were collected from each of six individuals who had undergone at least two liver biopsy examinations. Serum samples were collected prior to and following each liver biopsy and stored at k70 mC. Biopsies were assessed by a single pathologist, and scored according to both Knodell (Knodell et al., 1981) and Ishak (Ishak et al., 1995) systems for derivation of a histological activity index (HAI). Paired biopsies were read by the same pathologist, but without knowledge of the order of the biopsies. RNA extraction. RNA was recovered from 100 µl aliquots of sera as described by Chomczynski & Saachi (1987) using components from a commercially available RNA extraction kit (Stratagene), and resuspended in 20 µl of dH # O.
cDNA synthesis and HVR1 PCR. Eight µl of total RNA was used as template in randomly primed reverse transcription reactions to produce cDNA, using commercially available first-strand kits (Pharmacia).
One µl aliquots of HCV cDNA samples were used as templates in an HVR1 PCR. Amplification was achieved using a nested primer PCR method yielding products of nominally 820 and 308 bp in the first and second rounds, respectively. The primers used were : E1OS, outer, sense, position 819-841, 5h GGA CGG GGT AAA CTA TGC AAC AGG 3h ; E1IS, inner, sense, position 1304-1321, 5h TAT GAT GAT GAA CTG GTC 3h ; E1OA, outer, antisense, position 1614-1633, 5h TCA TTG CAG TTC AGG GCA GTC CTG TTG ATG 3h ; and E1IA, inner, antisense, position 1589-1612, 5h CTG TTG ATG TGC CAG CAG CCA TTG 3h. The primer positions correspond to the prototype HCV sequence of Choo et al. (1991) (GenBank accession no. M62321).
Estimation of HCV RNA titres. The HCV RNA titre was estimated according to the Poisson distribution formula based upon the frequency of positive PCRs at the end-point dilution, as described previously (Simmonds et al., 1990) . To improve accuracy, the viral titre in each sequential sample was estimated from the arithmetic mean of two to eight replicate end-point dilution PCR experiments.
Sequence and evolutionary analyses. For sequence analysis, single molecules of HCV cDNA obtained at the end-point dilution were PCR amplified and then directly sequenced using Big Dye fluorescent dye-terminator chemistry (Perkin Elmer). Sequencing templates were prepared by removing unincorporated primers and nucleotides from the PCR products using Exonuclease I and shrimp alkaline phosphatase (Amersham).
DNA sequence manipulation and phylogenetic analysis. DNA sequences were aligned using ClustalW (Thompson et al., 1994) . Phylogenetic relationships among sequences were estimated by the neighbour-joining method (Saitou & Nei, 1987) applied to pairwise distances estimated by the 2-parameter method (Kimura, 1980) . Sites at which there was a gap in any sequence in the alignment were excluded from all comparisons. The reliability of the phylogenetic results was assessed using 1000 bootstrap replicates (Felsenstein, 1985) . These analyses were performed using ClustalW.
Most recent common ancestral (MRCA) sequences were determined for each quasispecies using the marginal and joint maximum likelihood methods, as implemented in PAUP* version 4.0b4 (Messier & Stewart, 1997 ; Swofford, 1998) . Where possible, the MRCA was estimated from the neighbour-joining trees rooted to the clade containing the majority of the initial time-point sequences. For patients where there was no obvious major cluster of first time-point viruses, multiple analyses were carried out using each initial time-point sequence as outgroup.
The nature and rates of nucleotide substitutions were estimated and analysed essentially as described previously (Zhang et al., 1997) . Rates of inter-and intra-sample synonymous (Ks) and non-synonymous (Ka) nucleotide substitutions were estimated using the method described by Li (1993) , as implemented in the GCG version 9 software package. The resulting data matrix was used to estimate mean inter-and intra-sample Ka, Ks and Ka\Ks ratios. Pairwise comparisons of each sequence against the corresponding MRCA were also carried out.
Finally, protein translations were performed using GCG version 9.0, and the program  (Korber & Myers, 1992) was used to search for sequence signatures in each data set.
Diversity indices.
The viral population diversity in each sample was assessed by calculating the Shannon and Weiner diversity index (H) (Cronin & Raymo, 1997), using the formula : H lkΣ(p i nln p i ), where p i is the proportion of the total sequences represented by sequence i. This was calculated for both nucleotide and predicted amino acid sequences.
Sequence signature analysis. To determine whether specific amino acids were associated with disease status the program  was used to search for signature motifs. The analysis was carried out on all the patients' viral sequences or each patient's consensus sequence, using the virus obtained from individuals with mild and severe liver disease as background and query sequences, respectively. Due to the low number of patients and unequal number of sequence determinations, the analyses were repeated after the sequential stepwise removal of each of the patient's viral sequences. Only amino acids identified in all of these subreplicate analyses were considered to be significant. This ensured that any identified sequences were not biased by any one patient's viral sequences.
Statistical analyses. Evolutionary trends were assessed by a variety of tests available in the Prism GraphPad software package. Differences in sample means and medians were compared using unpaired BC HCV HVR1 evolution HCV HVR1 evolution t-tests and the Mann-Whitney U-test, respectively. Spearman's correlation coefficients were calculated to investigate association between data, linearity of plotted data were assessed using linear regression analysis, whilst differences in gradients were compared using F tests.
Sequence data. Nucleotide sequence data presented here have been deposited in the GenBank database under accession nos AF426476-AF426733.
Results

Patient categorization
The six patients included in this study all underwent at least two liver biopsies without intervening therapy. The patients were split into two groups defined as having either mild nonprogressive or severe progressive liver disease. Disease stage was scored using Knodell and Ishak scoring methods, both of which are combined necroinflammatory and fibrosis scores, together with the underlying fibrosis score (Table 1 ). The former patients fulfilled the following criteria : Knodell scores on any biopsy less than 5, no change in underlying fibrosis scores in paired biopsies (the pathologist considered one biopsy from one patient inadequate for the purpose of fibrosis assessment), and an increase in Knodell scores between biopsies of less than 3. The latter group had all three criteria of at least one biopsy having a Knodell score of greater than 5, an increase in underlying fibrosis stage of at least one between biopsies, and an increase in total Knodell score of greater than 3 between biopsies.
Viral loads and alanine transferase (ALT) data
The viral loads in each serum sample were estimated using an end-point titration RT-PCR method. The estimated RNA loads were based on the arithmetic mean of between two and eight repeat experiments and these data, together with the corresponding serum ALT values, are presented in Fig. 1 and Table 2 . RNA titres ranged from 10# n ( to 10' n ! copies per ml of serum. There was no significant difference (P 0n1) in mean viral load between individuals with mild or severe liver disease, with overall mean HCV RNA titres of 10% n ! and 10% n % copies per ml of serum, respectively. Fluctuations in the HCV RNA copy number of greater than 1 log between sample points were frequently observed.
A similar trend was observed for serum ALT levels. Some individuals had relatively stable values during the study whilst others, for example patient SP2, had significant flare-ups (Fig.  1) . In general, serum ALT values were higher in individuals with severe liver disease, which is reflected in the overall means presented in Table 2 . However, these differences were not statistically significant in unpaired t-tests (P 0n1). Peaks and troughs in ALT levels observed in patients SP1 and SP3 were associated with similar changes in viral RNA load, but this correlation was not statistically significant (P 0n1). The relative contribution of factors other than virus replication, e.g. alcohol consumption, was not known.
Sequence analysis
To ascertain the evolutionary trends observed in the HVR1 and flanking region we carried out extensive sequence analysis of virus populations present in each serum sample : 373 DNA sequences were obtained and the phylogenetic analysis of these data is shown in Fig. 2 . For each patient the clade containing the majority of the first time-point viruses was used as outgroup. Patient SP2 sequences did not cluster together : therefore, this tree was mid-point rooted.
For most patients sequence clusters corresponded to timepoint, although this was less noticeable for those individuals R. Curran and others R. Curran and others with severe liver disease. The topologies indicated that viral sequences derived from individuals with mild non-progressive liver disease (Fig. 2, upper the initial time-point. Instead, viral sequences present in samples obtained throughout the study were significantly more interspersed with each other. Finally, phylogenetic analysis of all the HVR1 sequences determined in this study revealed that all sequences clustered according to patient. This indicates that PCR cross-contamination between samples had not occurred. In addition, inclusion of the HVR1 and flanking region of sequences deposited in the GenBank database showed that patient MNP3 viruses were genotype 1a whilst the remaining patients' quasispecies clustered with genotype 3a viruses (not shown).
Intra-sample rates of nucleotide substitution
To assess this apparent difference in evolution in more detail, extensive pairwise comparisons of genetic distance, transition and transversion ratios and rates of synonymous (Ks), and non-synonymous (Ka) substitution were carried out. These data, plotted against the time at which the sequences were obtained, are presented in Fig. 3 . Wide fluctuations for all measurements within each patient were observed. The overall mean intra-sample genetic distance, Ka, Ks and Ka\Ks values (Table 3) were all higher in the combined data obtained from the patients with severe liver disease, although this difference was only statistically significant for the mean Ka\Ks ratios (P 0n05). On average, nucleotide substitutions in the HVR1 and flanking region caused by transitions were approximately 2n4-and 3n0-fold more frequent than those arising from transversions for individuals with mild and severe disease, respectively (Table 3) .
Analysis of intra-sample population diversity
Shannon and Weiner diversity indices were calculated to determine whether the viral population complexity at each time-point differed according to disease stage. The complexity of each virus population, both in terms of the relative abundance of distinct nucleic acid and amino acid variants, fluctuated over time (Fig. 4) . The mean diversity index for samples from patients with severe liver disease was statistically significantly higher than for samples from individuals with mild disease (Table 3) for both nucleotide (P 0n05) and amino acid (P 0n01) populations.
Analysis of the rates of nucleotide substitution
Measurements of cross-sectional population diversity and intra-sample substitution rates only provide a snapshot of the complexity of a virus population, and therefore may not be the best indication of the strength of selective pressure and subsequent response to this made by the virus population. Instead, determination of the rate at which nucleotide substitutions accumulate, and the nature of these accumulated changes, may provide better insight. To investigate this, the predicted most recent common ancestor (MRCA) for each patient's quasispecies was used in pairwise comparisons of genetic distance, Ka and Ks against the corresponding viral sequences (Fig. 5) . Viral quasispecies present in the sequential samples obtained from individuals with mild non-progressive liver disease showed a linear increase in genetic distance and rates of non-synonymous substitution. Least square regression (r) values for genetic distance were 0n77 (P 0n05), 0n98 (P 0n01) and 0n91 (P 0n001) and for Ka were 0n75 (P 0n05), 0n98 (P 0n01) and 0n92 (P 0n001) for patients MNP1, MNP3 and MNP2, respectively. A similar evolutionary relationship was not evident in the populations obtained from the three patients with severe progressive liver disease. There was no obvious relationship between Ks or Ka\Ks ratios for any of the viral populations. Essentially the same results were obtained when the analysis was carried out using sequences obtained at the initial time-point compared with all subsequent sequences (not shown).
The gradients, and hence rates, of total and non-synonymous substitution for the virus associated with mild disease were compared using an F test, and both differed significantly between patients (P 0n0001). The rates of nucleotide and non-synonymous substitutions for the HVR1 and flanking region, as determined from the gradient of each line, were 2n26i10 −$ , 6n59i10 −$ and 3n36i10 −$ nucleotide substitutions per site per year and 1n78i10 −$ , 5n14i10 −$ and 2n92i10 −$ non-synonymous substitutions per nonsynonymous site per year for patients MNP1, MNP3 and MNP2, respectively.
Amino acid comparisons and signature sequence analysis
As expected the alignments of the deduced amino acids for the viral populations obtained for each patient showed that most of the mutations clustered around the hypervariable BF R. Curran and others R. Curran and others 
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Liver disease status Mild Severe
Mean genetic distance ( %) 1n41 (0n26-3n98) 1n66 (0n49-4n60) Mean Ka 0n95 (0n00-3n46) 1n34 (0n14-4n73) Mean Ks 2n44 (0n77-5n70) 2n02 (0n15-4n07) Mean Ka\Ks 0n34 (0n00-0n90) 1n01 (0n11-6n33) Mean transition\transversion ratio 2n37 (1n81-2n89) 2n95 (2n22-3n42)
Mean diversity index Nucleic acid sequences 1n55 (0n60-2n37) 1n87 (0n95-2n37) Amino acid sequences 0n74 (0n00-2n02) 1n27 (0n35-2n16) region (not shown). Insertions and deletions were rare, although one sequence obtained from patient SP3 had a 21 amino acid deletion located in the cytoplasmic tail of E1 upstream of HVR1 and one obtained from patient MNP2 contained a single nucleotide deletion. This deletion resulted in a frameshift and hence a premature stop codon downstream of HVR1 (not shown).
To determine whether specific amino acids were associated with disease status the program  was used to search for signature motifs. Whilst six amino acid positions differed according to disease status, none were unique to either group of patients. A similar analysis of the consensus sequences for each patient did not provide any evidence for the presence of a disease stage-associated signature motif.
Discussion
The most significant factor that enabled us to carry out this study was access to individuals who had severe liver disease and had not received antiviral therapy. There were only three patients in our cohort (of over 2000 patients) with severe Fig. 2 . Phylogenetic analysis of HCV RNA sequences, corresponding to the HVR1 and upstream flanking region in individuals with disparate liver disease severity. HCV RNA sequences were derived from individuals with either mild non-progressive (patients MNP1, MNP2 and MNP2) or severe progressive (patients SP1, SP2 and SP3) liver disease. Upper-case letters indicate the sequential time-point at which each sequence was derived in ascending order and numbers in parentheses indicate the frequency at which it was detected. Branches supported in more than 70 % and 90 % of bootstrap replicate trees are denoted with ' * ' and ' ** ', respectively. The position of the MRCA sequence inferred by maximum likelihood methods is indicated by ' θ '. disease who had refused therapy and from whom sequential serum and biopsies were available. This indicates the extreme difficulty there is in recruiting patients for this type of study, and perhaps in part explains why such an obvious study has not been carried out previously.
Assignment of patients to an appropriate disease state group is clearly crucial to this analysis. Assessment of liver disease severity by measurement of histological activity indices is an arbitrary process subject to a number of sources of potential bias. Several steps were taken to minimize these.
(1) To avoid inter-observer bias, all biopsies were read by a single pathologist, blinded to the temporal order of the biopsies. (2) We used Knodell and Ishak scoring to categorize patients. (3) We included change in the sub-score of fibrosis as one of the defining criteria for patient categorization, as this is the most important indicator of progression to clinically significant liver disease and failure. In this way we pre-selected six patients falling in to two polarized groups using the multiple defining criteria of either mild\non-progressive or severe\progressive liver disease. No significant differences in serum ALT levels or viral titres were observed between individuals with mild or severe disease, and this is in keeping with previous studies (Fanning et al., 2000 ; Hollingsworth et al., 1996 ; Puoti et al., 1997) .
To assess the rates of virus evolution in each of the patients, we carried out extensive sequence analysis. For this, directly sequencing end-point diluted cDNA was preferred to the analysis of cloned PCR products as it overcomes problems associated with the infidelity of PCR (even when using proofreading enzymes) and artefactual recombination events (Meyerhans et al., 1990 ; Simmonds et al., 1990) . The population diversity was more complex in individuals with severe liver disease and the ratio of amino acid-changing to silent substitutions was also higher. Similar observations were made in a recent study carried out by Cabot et al. (2000) . It is important to note that the intra-sample values for all parameters fluctuated widely in each patient and this may explain, at least in part, why previous cross-sectional studies are in disagreement about the association of quasispecies complexity and liver disease (Hayashi et al., 1997 ; Honda et al., 1994 ; Lopez-Labrador et al., 1999 ; Naito et al., 1995 ; Yuki et al., 1997) .
To assess how a virus population evolves over time, comparisons have to be made to a known ancestral sequence. In this study we inferred a most recent common ancestor (MRCA) using maximum likelihood methods. Evolution of BH R. Curran and others R. Curran and others Fig. 3 . Intra-sample genetic distance, Ka, Ks and Ka/Ks values from sequential plasma-derived HCV RNA sequences from individuals with disparate liver disease severity. Data obtained from patients with mild non-progressive liver disease, patients MNP1 (>), MNP2 ($) and MNP3 (), or severe progressive liver disease, patients SP1 ( ), SP2 (6) and SP3 (=) are presented in panels (A) and (B), respectively. Each value represents the mean of all pairwise comparisons of sequences derived from each time-point plotted against time. each patient's quasispecies could then be revealed by pairwise comparison of each sequence to this MRCA. Significant and consistent differences in the rates and nature of nucleotide substitution were apparent between the two groups of patients. In the three patients with severe liver disease the virus population was unusually stable. By contrast there was a linear increase in genetic distance and rates of Ka substitutions for the virus populations in all three individuals with mild liver disease. The fact that these relationships were statistically significant for all three patients means they are unlikely to be due to chance.
Why disparate rates of evolution were apparent in individuals with different disease severity is intriguing. The virus evolution observed in patients with mild non-progressive disease indicates positive selection. Considering that the HVR1 region is known to induce antibody and cell mediated immunity this would not be surprising. Immune-driven changes have been reported following parenteral and vertical transmission as well as during chronic infection (Farci et al., 2000 ; Manzin et al., 2000 ; Ray et al., 1999) . In contrast, the relatively stable quasispecies observed in individuals with severe liver disease suggest that the virus population is either not subject to selection or is able to respond to selection without significant changes in the population composition. The relatively high intra-sample Ka\Ks values indicate that the diverse populations are, or have been, exposed to selective pressure and the simplest explanation for the relative evolutionary stasis would be that equilibrium between host immune responses and the viral quasispecies had developed.
A possible model to explain these findings is that following acute infection by a relatively homogeneous virus population, host immune responses drive HVR1 evolution (Farci et al., 1990) and this continues throughout early stages causing the virus population to diverge away from the initial population. However, selection does not bring about extinction of all variants and some lineages may persist for long periods (McAllister et al., 1998) . This would lead to population diversification and eventual equilibrium between selective pressure (both immune and other pressures, e.g. cell tropism) and the viral quasispecies. Establishment of this equilibrium would be a gradual process, as is development of severe disease. Therefore, rather than being causative or conse-R. Curran and others R. Curran and others CA quential, the relationship between evolution and disease severity might be coincidental.
An alternative model is that continuous evolution of HCV and subsequent immune escape during chronic infection might eventually lead to loss of immune control via the process of ' original antigenic sin ' or clonal imprinting (Holzmann et al., 1996 ; Taylor et al., 1996 ; Natali et al., 1996 ; Klenerman & Zinkernagel, 1998) . Loss of immune control might be expected to result in an increase in viral titre, which we didn't observe. However, other factors, such as the number of cells capable of supporting infection, might be more important in limiting population size.
It is also possible that alternative virus reservoirs protected from immune pressures, so-called sanctuary sites, exist. HCV population differences have been reported for liver, serum and other tissues (Cabot et al., 2000 ; Laskus et al., 2000 ; Navas et al., 1998) . Evolution of variants with distinct cytopathic effect and cell tropism is thought to be a late event during HIV infection (Berger et al., 1998 ; Schuitemaker et al., 1992) . Importantly, co-receptor tropism and tissue distribution of HIV-1 are associated with the acquisition of amino acid mutations in the third hypervariable region (Ball et al., 1994 ; Fouchier et al., 1992) , a region of HIV-1 that is analogous to HVR1. Unfortunately, neither our or other studies (Ray et al., 1999) have identified amino acid signatures associated with disease severity.
In conclusion, we have shown that significantly different HVR1 evolutionary trends are observed in individuals with disparate liver disease severity. Although this study involved an unavoidably small number of patients the data obtained were very consistent. It is important to remember that the differences observed between the two groups of patients may not be associated with disease pathology but with other factors such as duration of the infection. Irrespective of these caveats, these findings provide an intriguing insight into the evolution of HCV during chronic infection. Genetic drift of hepatitis C virus during an 8n2 year infection in a chimpanzee : variability and stability. Virology 190, 894-899.
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